Evidence map›Paper›PMID 38632829›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.

Maunank Shah, Zoe Dansky, Ruvandhi Nathavitharana, Heidi Behm, Shaka Brown, Lana Dov, Diana Fortune, Nicole Linda Gadon, Katelynne Gardner Toren, Susannah Graves and 6 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Community-Based Tuberculosis Isolation Decisions Require Individualization Based on Effectiveness and Duration of Treatment, Community Risks, and Patient Harms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maunank ShahDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-0979-2388
Zoe DanskyDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Ruvandhi NathavitharanaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA.
Heidi BehmTB Program, Oregon Health Authority, Portland, OR, USA.
Shaka BrownWe are TB, Stop TB  USA.
Lana DovWashington State Department of Health, WA, USA.
Diana FortuneNational Tuberculosis Controllers Association, Smyrna, GA, USA.
Nicole Linda GadonWe are TB, Stop TB  USA.
Katelynne Gardner TorenPublic Health Seattle and King County Tuberculosis Control Program, WA, USA.
Susannah GravesDepartment of Public Health, City and County of San Francisco, CA, USA.
Connie A HaleyDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, TN, USA.
Olivia KatesDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Nadya SabuwalaMinnesota Department of Health, MN, USA.
Donna WegenerNational TB Coalition of America, USA.
Kathryn YooSociety of Epidemiologists in Tuberculosis Control (SETC); Texas Department of State Health Services, Tuberculosis and Hansen's Disease Unit (TXDSHS), TX, USA.
Joseph BurzynskiNew York City Department of Health and Mental Hygiene, New York, NY, USA.

Funding

Pharmacology and Pharmacometrics CoreP30AI168436 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Petros C Karakousis · 2022 to 2026
$6.1M
THWART-TB : Testing Health Workers At Risk to advance our understanding of TB infectionDP2AI176896 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Ruvandhi Nathavitharana · 2023 to 2026
$1.6M
Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care FacilitiesK23AI132648 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NATHAVITHARANA, RUVANDHI · 2018 to 2022
$945k
NIAID NIH HHS DP2 AI176896NIAID NIH HHS K23 AI132648NIAID NIH HHS P30 AI168436
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38632829
PMCPMC13675926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.